A safety committee will review all evidence from trials and studies to shed more light on the potential risk of NAION.

A study comparing men and women suggests much of the association arises from genetic propensity to both conditions.

More than one-third of websites selling their own versions implied the products were the same as the FDA-approved drugs.

In a field rife with disagreement, STS, AATS, and others say the European guidelines got it right when it comes to CABG.

Clinicians and patients alike have lost homes and possessions, but cardiovascular care in Los Angeles remains robust.

Fitness doesn’t make people immune to atherosclerosis, but what to do with the finding in asymptomatic patients is uncertain.

In the year before amputation, a deep divide was seen between patients who got specialist care and those who did not.

Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.

Vinod Thourani and Larry Epstein explore the current field of tricuspid intervention as well as challenges within lead ...